SEC Form 4
Medtronic plc (MDT) insider trading
In the 12 months to Oct 24, 2026, 5 MDT insiders reported open-market sales of $14.7M across 7 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $14.7M
- 7 filings · 5 insiders
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 3 of 7
- $6.0M of $14.7M sold (41%)
Who traded MDT, and when
- Sale
- Sale, pre-arranged (10b5-1)
MDT daily close from Oct 24, 2025 to Oct 23, 2026, between $73.75 and $105.35, last $95.41. 7 sale and 0 purchase filings by 5 insiders, marked at their filing dates. Harry Skip Kiil, EVP & President Cardiovascular: sold $5.6M across 3 filings, first filed Feb 26, 2026, last Sep 17, 2026. Geoffrey Martha, Chairman and CEO: sold $4.8M across 1 filing, first filed Oct 16, 2026, last Oct 16, 2026. Gregory L. Smith, EVP Global Ops & Supply Chain: sold $3.1M across 1 filing, first filed Nov 21, 2025, last Nov 21, 2025. Michael Marinaro, EVP, Pres MedSurg and Americas: sold $1.0M across 1 filing, first filed Oct 16, 2026, last Oct 16, 2026. Matthew R. Walter, SVP, Chief HR Officer: sold $257.9K across 1 filing, first filed Jul 9, 2026, last Jul 9, 2026.
Largest mark · tap a row for others
Harry Skip Kiil · EVP & President Cardiovascular
Sale $5,132,217
52,524 shares
Filed Feb 26, 2026 · traded Feb 19
Close on filing date $97.03
Harry Skip Kiil · EVP & President Cardiovascular
EVP & President Cardiovascular
$5.6M soldGeoffrey Martha · Chairman and CEO
Chairman and CEO
$4.8M soldGregory L. Smith · EVP Global Ops & Supply Chain
EVP Global Ops & Supply Chain
$3.1M soldMichael Marinaro · EVP, Pres MedSurg and Americas
EVP, Pres MedSurg and Americas
$1.0M soldMatthew R. Walter · SVP, Chief HR Officer
SVP, Chief HR Officer
$257.9K soldHas Medtronic plc's CEO sold stock?
Yes. Geoffrey Martha (CEO) sold 50,000 shares ($4.8M) in Oct 2026, all under a pre-arranged 10b5-1 plan.
Open-market trades
7 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Harry Skip Kiil | EVP & President Cardiovascular | $5.6M | — | 3 | — | |
| Geoffrey Martha | Chairman and CEO | $4.8M | — | 1 | 100% of sales | |
| Gregory L. Smith | EVP Global Ops & Supply Chain | $3.1M | — | 1 | — | |
| Michael Marinaro | EVP, Pres MedSurg and Americas | $1.0M | — | 1 | 100% of sales | |
| Matthew R. Walter | SVP, Chief HR Officer | $257.9K | — | 1 | 100% of sales |
| Filed | Insider | Type | Shares | Value | Held after | Source |
|---|---|---|---|---|---|---|
traded | Geoffrey Martha Chairman and CEO | SalePre-arranged (10b5-1) | 50,000 ordinary shares | $4.8M | 277,866 | |
traded | Michael Marinaro EVP, Pres MedSurg and Americas | SalePre-arranged (10b5-1) | 10,420 ordinary shares | $1.0M | 105,916 | |
traded | Harry Skip Kiil EVP & President Cardiovascular | Sale | 1,483 ordinary shares | $138.9K | 42,186 | |
traded | Matthew R. Walter SVP, Chief HR Officer | SalePre-arranged (10b5-1) | 3,102 ordinary shares | $257.9K | 35,694 | |
traded | Harry Skip Kiil EVP & President Cardiovascular | Sale | 4,189 ordinary shares | $337.0K | 37,227 | |
traded | Harry Skip Kiil EVP & President Cardiovascular | Sale | 52,524 ordinary shares | $5.1M | 32,768 | |
traded | Gregory L. Smith EVP Global Ops & Supply Chain | Sale | 30,000 ordinary shares | $3.1M | 51,830 |
Shares are as filed (ordinary shares or ADS); values are as converted to US$ in the filing.
GET /stocks/filings/vX/form-4?tickers=MDT&filing_date.gte=2025-10-24&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"MDT"
],
"issuer_cik": "0001613103",
"owner_cik": "0001560409",
"accession_number": "0001560409-26-000011",
"form_type": "4",
"filing_date": "2026-10-16",
"period_of_report": "2026-10-15",
"issuer_name": "Medtronic plc",
"issuer_trading_symbol": "MDT",
"owner_name": "Martha Geoffrey",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chairman and CEO",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 50000,
"transaction_price_per_share": 95,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 277866,
"transaction_value": 4750000,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"remarks": "This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on July 16, 2026."
},
{
"tickers": [
"MDT"
],
"issuer_cik": "0001613103",
"owner_cik": "0001984186",
"accession_number": "0001984186-26-000010",
"form_type": "4",
"filing_date": "2026-10-16",
"period_of_report": "2026-10-15",
"issuer_name": "Medtronic plc",
"issuer_trading_symbol": "MDT",
"owner_name": "Marinaro Michael",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "EVP, Pres MedSurg and Americas",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Ordinary Shares",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-10-15",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 10420,
"transaction_price_per_share": 96,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 105916,
"transaction_value": 1000320,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"remarks": "This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 17, 2026."
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 63 records
- Option exercises9 records
- Tax withholding29 records
- Grants and awards21 records
- Gifts3 records
- Other1 record
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
Build this yourself
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MDT every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.